It's difficult to evaluate their performance. We don't know if they've had any decent offers to partner/sell and it's really early into the launch. They've diluted like drunken sailors to get this far. It makes me nauseous. I said we could end up in the 4's. Now $2.50 is possible. Crazy considering the quality of the drug. You'd think there would be more interest.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.